Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Incretin hormones and type 2 diabetes
GLP-1 Receptor Agonist Market Key Takeaways Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer, Inc., Amgen, Inc., Innovent Biologics, Inc., PegBio Co., Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH Increasing prevalence of chronic diseases such as diabetes and obesity Increasing R&D activities for developing novel therapeutics Formulation advancements of oral GLP-1 receptor agonists Adverse effects associated with few GLP-1 agonist drugs Product recalls by market players With the increasing prevalence of diabetes and obesity, GLP-1 receptor agonists have become popular due to their effectiveness in glycemic control and weight reduction, offering a dual benefit in managing type 2 diabetes mellitus (T2DM)
Q: Where should I store these tablets to maintain their effectiveness
The GLP-1 and GIP components function similarly to tirzepatide, providing appetite suppression, improved insulin dynamics, and reduced caloric intake
US$ 21.67
US$ 27.34
US$ 22.51
US$ 28.77
US$ 20.41
